Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures

Creative Commons License

Kurt M., Onal I. K., Akdogan M., KEKİLLİ M., Arhan M., Sayilir A., ...Daha Fazla

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.24, sa.6, ss.380-384, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 6
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1155/2010/896819
  • Dergi Adı: CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.380-384
  • Anahtar Kelimeler: Ankaferd Blood Stopper, Bleeding, Dieulafoy's lesion, Mallory-Weiss tear, Polypectomy, Radiation colitis, MALLORY-WEISS-SYNDROME, ANTRAL VASCULAR ECTASIA, COMPLICATION, EFFICACY, ULCER, MODEL
  • Gazi Üniversitesi Adresli: Hayır

Özet

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.